This Week in PLoS | GenomeWeb

This Week in PLoS

Researchers at the University of North Carolina, Chapel Hill have developed a six-gene signature that may better identify the disease stage of pancreatic ductal adenocarcinoma patients, as they report in PLoS Medicine. The researchers identified six genes that were differentially over-expressed between nonmetastatic and metastatic tumors and then applied them to a training set and an independent cohort.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.